CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −1,733 | $264.12 | $458K | 35,593 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −3,557 | $265.08 | $943K | 32,036 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −8,986 | $266.18 | $2.4M | 23,050 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −11,673 | $266.97 | $3.1M | 11,377 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −6,671 | $268.04 | $1.8M | 4,706 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −3,963 | $268.97 | $1.1M | 743 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −370 | $269.83 | $100K | 373 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −373 | $271.09 | $101K | 0 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −62 | $263.05 | $16K | 107,300 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −900 | $264.60 | $238K | 106,400 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −1,604 | $265.54 | $426K | 104,796 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −4,339 | $266.62 | $1.2M | 100,457 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −1,891 | $267.37 | $506K | 98,566 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −1,674 | $268.67 | $450K | 96,892 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −930 | $269.50 | $251K | 95,962 |
| 2026-02-24 | JANNEY DANIEL Director | Sale 10b5-1 | −2,425 | $274.90 | $667K | 93,537 |
| 2026-02-24 | JANNEY DANIEL Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,895 | 0 | ||
| 2026-02-19 | ROSSI DINO A Director | Option exercise | +18,950 | $8.79 | $167K | 97,641 |
| 2026-02-19 | ROSSI DINO A Director | Sale | −8,116 | $260.49 | $2.1M | 89,525 |
| 2026-02-19 | ROSSI DINO A Director | Sale | −10,834 | $262.10 | $2.8M | 78,691 |
Page 8 of 35 · 689 trades